Dark
Light
Today: September 23, 2024

Adrian Johnson

CereVasc Secures $70M in Series B Funding

TLDR: CereVasc, a medical device company, raised $70M in Series B funding led by Bain Capital Life Sciences and Perceptive Xontogeny Venture Fund. The funds will support the development of its eShunt
May 14, 2024
1 352 353 354 355 356 677
Go toTop